A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Study Identifier
192024-035
CT.gov Identifier
NCT00538304
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Glaucoma - Other
  • Ocular Hypertension
    • Study Drug
  • bimatoprost eye drops
  • placebo
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Chronic glaucoma or ocular hypertension * IOP controlled on Xalatan
    Exclusion Criteria:
    * Uncontrolled medical conditions * Known hypersensitivity to study medications

    Protocol Summary

    A one month study which will determine the safety and efficacy of bimatoprost eye drops in patients with glaucoma or ocular hypertension

    Study Locations

    Location
    Status
    Location
    Atlanta, Georgia, United States
    Status
    Not applicable